Home/Filings/4/0001225208-22-006331
4//SEC Filing

Scanlon Meghan 4

Accession 0001225208-22-006331

CIK 0000885725other

Filed

May 1, 8:00 PM ET

Accepted

May 2, 4:33 PM ET

Size

8.0 KB

Accession

0001225208-22-006331

Insider Transaction Report

Form 4
Period: 2022-05-01
Scanlon Meghan
SVP,Pres,Urology Pelvic Health
Transactions
  • Exercise/Conversion

    Common Stock

    2022-05-01+2,06225,067 total
  • Tax Payment

    Common Stock

    2022-05-01$42.11/sh606$25,51924,461 total
  • Exercise/Conversion

    Deferred Stock Units

    2022-05-012,0622,062 total
    Exp: 2023-05-01Common Stock (2,062 underlying)
Footnotes (2)
  • [F1]Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
  • [F2]Shares of common stock will be issued to the reporting person in four equal annual installments beginning on May 1, 2020, the first anniversary of the date of grant.

Documents

1 file

Issuer

BOSTON SCIENTIFIC CORP

CIK 0000885725

Entity typeother

Related Parties

1
  • filerCIK 0001801586

Filing Metadata

Form type
4
Filed
May 1, 8:00 PM ET
Accepted
May 2, 4:33 PM ET
Size
8.0 KB